NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,768 Cr | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,768 Cr |
| Mar2025 | ₹1,697 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹849 Cr |
| Mar2022 | ₹47 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,768 Cr | 4.21 | |
| Mar2025 | ₹1,697 Cr | 40.05 | |
| Mar2024 | ₹1,212 Cr | 42.69 | |
| Mar2023 | ₹849 Cr | 1,726.02 | |
| Mar2022 | ₹47 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,077.5 Cr | 3.4% | -2.8% | -5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.4% |
-2.8% |
-5.3% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses